vs

Side-by-side financial comparison of Axon Enterprise (AXON) and Genius Sports Ltd (GENI). Click either name above to swap in a different company.

Axon Enterprise is the larger business by last-quarter revenue ($796.7M vs $510.9M, roughly 1.6× Genius Sports Ltd). Axon Enterprise runs the higher net margin — 0.3% vs -12.3%, a 12.7% gap on every dollar of revenue. Axon Enterprise produced more free cash flow last quarter ($155.4M vs $69.6M). Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 31.5%).

Axon Enterprise, Inc. is an American company based in Scottsdale, Arizona, that develops weapons and technology products for military, law enforcement, and civilians.

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

AXON vs GENI — Head-to-Head

Bigger by revenue
AXON
AXON
1.6× larger
AXON
$796.7M
$510.9M
GENI
Higher net margin
AXON
AXON
12.7% more per $
AXON
0.3%
-12.3%
GENI
More free cash flow
AXON
AXON
$85.9M more FCF
AXON
$155.4M
$69.6M
GENI
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
31.5%
AXON

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AXON
AXON
GENI
GENI
Revenue
$796.7M
$510.9M
Net Profit
$2.7M
$-63.0M
Gross Margin
57.9%
25.2%
Operating Margin
-6.3%
-11.5%
Net Margin
0.3%
-12.3%
Revenue YoY
38.9%
Net Profit YoY
-98.0%
EPS (diluted)
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXON
AXON
GENI
GENI
Q4 25
$796.7M
$510.9M
Q3 25
$710.6M
$335.4M
Q2 25
$668.5M
$215.2M
Q1 25
$603.6M
$119.7M
Q4 24
$573.4M
$413.0M
Q3 24
$544.3M
$285.8M
Q2 24
$504.1M
$184.1M
Q1 24
$460.7M
$97.2M
Net Profit
AXON
AXON
GENI
GENI
Q4 25
$2.7M
$-63.0M
Q3 25
$-2.2M
Q2 25
$36.1M
$-47.3M
Q1 25
$88.0M
$-25.5M
Q4 24
$136.0M
$-85.5M
Q3 24
$67.0M
$-47.1M
Q2 24
$40.8M
$-35.5M
Q1 24
$133.2M
$-25.2M
Gross Margin
AXON
AXON
GENI
GENI
Q4 25
57.9%
25.2%
Q3 25
60.1%
24.2%
Q2 25
60.4%
19.1%
Q1 25
60.6%
10.7%
Q4 24
60.5%
16.7%
Q3 24
60.8%
20.5%
Q2 24
60.3%
18.6%
Q1 24
56.4%
9.8%
Operating Margin
AXON
AXON
GENI
GENI
Q4 25
-6.3%
-11.5%
Q3 25
-0.3%
-15.3%
Q2 25
-0.2%
-21.0%
Q1 25
-1.5%
-20.3%
Q4 24
-2.6%
-18.0%
Q3 24
4.4%
-13.9%
Q2 24
6.5%
-16.8%
Q1 24
3.5%
-23.7%
Net Margin
AXON
AXON
GENI
GENI
Q4 25
0.3%
-12.3%
Q3 25
-0.3%
Q2 25
5.4%
-22.0%
Q1 25
14.6%
-21.3%
Q4 24
23.7%
-20.7%
Q3 24
12.3%
-16.5%
Q2 24
8.1%
-19.3%
Q1 24
28.9%
-25.9%
EPS (diluted)
AXON
AXON
GENI
GENI
Q4 25
$0.02
Q3 25
$-0.03
Q2 25
$0.44
Q1 25
$1.08
Q4 24
$1.68
Q3 24
$0.86
Q2 24
$0.53
Q1 24
$1.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXON
AXON
GENI
GENI
Cash + ST InvestmentsLiquidity on hand
$1.7B
$280.6M
Total DebtLower is stronger
$1.8B
Stockholders' EquityBook value
$3.2B
$724.5M
Total Assets
$7.0B
$1.1B
Debt / EquityLower = less leverage
0.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXON
AXON
GENI
GENI
Q4 25
$1.7B
$280.6M
Q3 25
$2.4B
$110.2M
Q2 25
$2.1B
$110.2M
Q1 25
$2.2B
$110.2M
Q4 24
$788.1M
$100.3M
Q3 24
$1.0B
$100.3M
Q2 24
$968.9M
$100.3M
Q1 24
$964.1M
$100.3M
Total Debt
AXON
AXON
GENI
GENI
Q4 25
$1.8B
Q3 25
$2.0B
Q2 25
$2.0B
Q1 25
$2.0B
Q4 24
$680.3M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AXON
AXON
GENI
GENI
Q4 25
$3.2B
$724.5M
Q3 25
$3.0B
$572.4M
Q2 25
$2.7B
$572.4M
Q1 25
$2.6B
$572.4M
Q4 24
$2.3B
$573.0M
Q3 24
$2.1B
$573.0M
Q2 24
$1.9B
$573.0M
Q1 24
$1.8B
$573.0M
Total Assets
AXON
AXON
GENI
GENI
Q4 25
$7.0B
$1.1B
Q3 25
$6.7B
$792.3M
Q2 25
$6.2B
$792.3M
Q1 25
$6.1B
$792.3M
Q4 24
$4.5B
$775.7M
Q3 24
$4.0B
$775.7M
Q2 24
$3.7B
$775.7M
Q1 24
$3.6B
$775.7M
Debt / Equity
AXON
AXON
GENI
GENI
Q4 25
0.56×
Q3 25
0.66×
Q2 25
0.73×
Q1 25
0.79×
Q4 24
0.29×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXON
AXON
GENI
GENI
Operating Cash FlowLast quarter
$217.2M
$81.9M
Free Cash FlowOCF − Capex
$155.4M
$69.6M
FCF MarginFCF / Revenue
19.5%
13.6%
Capex IntensityCapex / Revenue
7.8%
2.4%
Cash ConversionOCF / Net Profit
79.14×
TTM Free Cash FlowTrailing 4 quarters
$75.1M
$33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXON
AXON
GENI
GENI
Q4 25
$217.2M
$81.9M
Q3 25
$60.0M
$-4.8M
Q2 25
$-91.7M
$-1.2M
Q1 25
$25.8M
$-14.6M
Q4 24
$250.2M
$14.9M
Q3 24
$91.3M
$-9.2M
Q2 24
$82.8M
Q1 24
$-15.9M
Free Cash Flow
AXON
AXON
GENI
GENI
Q4 25
$155.4M
$69.6M
Q3 25
$33.4M
$-14.2M
Q2 25
$-114.7M
$-5.8M
Q1 25
$932.0K
$-16.0M
Q4 24
$225.4M
$11.3M
Q3 24
$64.8M
$-11.6M
Q2 24
$71.4M
Q1 24
$-32.1M
FCF Margin
AXON
AXON
GENI
GENI
Q4 25
19.5%
13.6%
Q3 25
4.7%
-4.2%
Q2 25
-17.2%
-2.7%
Q1 25
0.2%
-13.4%
Q4 24
39.3%
2.7%
Q3 24
11.9%
-4.1%
Q2 24
14.2%
Q1 24
-7.0%
Capex Intensity
AXON
AXON
GENI
GENI
Q4 25
7.8%
2.4%
Q3 25
3.7%
2.8%
Q2 25
3.4%
2.1%
Q1 25
4.1%
1.2%
Q4 24
4.3%
0.9%
Q3 24
4.9%
0.9%
Q2 24
2.2%
Q1 24
3.5%
Cash Conversion
AXON
AXON
GENI
GENI
Q4 25
79.14×
Q3 25
Q2 25
-2.54×
Q1 25
0.29×
Q4 24
1.84×
Q3 24
1.36×
Q2 24
2.03×
Q1 24
-0.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXON
AXON

Software And Sensors Segment$342.5M43%
TASER Devices Professional$264.2M33%
Personal Sensors$109.1M14%
Platform Solutions$80.9M10%

GENI
GENI

Segment breakdown not available.

Related Comparisons